HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Sulfaphenazole

HCID 5335
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
526-08-9
Standard SMILES
Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1
InChIKey
QWCJHSGMANYXCW-UHFFFAOYSA-N
Molecular formula
C15H14N4O2S
Average molar mass
314.4 g/mol
Monoisotopic mass
314.08374688

Overview

Sulfaphenazole is a sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent. It has a role as an antibacterial drug, a P450 inhibitor, an EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor and an EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor. It is a member of pyrazoles, a sulfonamide, a substituted aniline, a primary amino compound and a sulfonamide antibiotic.

Names & identifiers

Preferred name
Sulfaphenazole
IUPAC
4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide
English name
SULFAPHENAZOLE
Molecular formula
C15H14N4O2S
Molecular weight
314.36

Names & synonyms

sulfaphenazole526-08-9SulphaphenazoleSulfabid4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamideSulfafenazolSulfaphenazolSulfaphenazolumSulfafenazoloSulfaphenylpyrazol1-Phenyl-5-sulfanilamidopyrazole5-Sulfanilamido-1-phenylpyrazole
Show more names
SPTFF2Trefoil factor 2SulfaphenylpyrazoleSML1OrisulInamil
N'-(1-Phenylpyrazol-5-yl)sulfanilamide4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamidePhenylsulfapyrazoleOrisulf3-(p-Aminobenzenesulfonamido)-2-phenylpyrazoleBenzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-DTXSID20441314-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzene-1-sulfonamide

Database identifiers

CAS
526-08-9
PubChem CID
5335
DTXSID
DTXSID2044131
ChEMBL
CHEMBL1109
ChEBI
CHEBI:77780

Properties

Computed structural propertiesFilling in

XLogP
1.5
Topological polar surface area
98.4 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
4
Heavy atoms
22
Formal charge
0
Complexity
451

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics

LogP · 2 items

1.52

1.35

Solubility0.6 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Melting Point101 °C
Physical DescriptionSolid
Collision Cross Section · 2 items

157.93 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

170 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

PPE
Eyeshields, Gloves, type N95 (US)
wgk
2
rtecs
DA9520000
hs_code
29339900
Toxicity
LD50 orally in mice: 5800 mg/kg (Seki)
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
24/25
Storage Class
11 - Combustible Solids
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 4 items

S - Sensory organs

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

QS - Sensory organs

Mechanism of Action · 1 item

Sulfaphenazole is a sulfonamide antibacterial. In bacteria, antibacterial sulfonamides act as competitive inhibitors of the enzyme dihydropteroate synthetase (DHPS), an enzyme involved in folate synthesis. As such, the microorganism will be "starved" of folate and die.

Metabolism/MetabolitesHepatic.
MeSH Pharmacological ClassificationSubstances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Cellular LocationsMembrane

Uses & manufacturing

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Applications · 4 items

DescriptionCYP2C9 is a major cytochrome P450 enzyme that is involved in the metabolic clearance of various therapeutic agents. Disruption of this enzyme’s activity can lead to adverse drug reactions. Sulfaphenazole is an inhibitor of CYP2C9 (Ki = 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Kis = 63 and 29 μM for CYP2C8 and CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19). At 10 μM, sulfaphenazole has been shown to inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells and modulates vascular tone and homeostasis.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
0J8L4V3F81
EC Number
208-384-3
Nikkaji
J2.062A

Physicochemical properties

Melting point
179 · 179-183 °C
Boiling point
541.9 · 541.9±56.0 °C(Predicted)
Density
1.39 · 1.39
refractive index
1.644 · 1.6440 (estimate)
storage temp.
2 · 2-8°C
solubility
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
5.71 · pKa 5.71(H2O t = 25 I = 0.05) (Uncertain)
color
white to light yellow
InChI
InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2
InChIKey
QWCJHSGMANYXCW-UHFFFAOYSA-N
SMILES
C1(S(NC2N(C3=CC=CC=C3)N=CC=2)(=O)=O)=CC=C(N)C=C1
EWG's Food Scores
1 · 1
FDA UNII
0 J8L4V3F81 · 0J8L4V3F81
ATC code
1 ED08 · J01ED08
UNSPSC Code
12352204 · 12352204
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P301+P312-P302+P352-P304+P340-P305+P351+P338
PPE
95 · Eyeshields, Gloves, type N95 (US)
Safety Statements
24 · 24/25
WGK Germany
2 · 2
RTECS
9520000 · DA9520000
HS Code
29339900 · 29339900
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 orally · LD50 orally in mice: 5800 mg/kg (Seki)

UsesSulfaphenazole is used as an inhibitor for mammalian CYP2C9, an enzyme of the cytochrome P450 family allowing for pharmacological application.Sulfaphenazole can help protect against ischemia-reperfusion, and resulting tissue damage by inhibition of CYP2C9.

UsesSulfaphenazole has been used as a positive control to inhibit cytochrome P450 2C9 (cyp2c9) to quantify Rhodiola rosea inhibition. It has also been used as cytochrome P450 2C9 (cyp2c9) inhibitor in endothelial cells and microsomal preparations.

DescriptionTFF-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 106 amino acids (24-129) and having a total molecular mass of 12 kDa. TFF2 Human Recombinant includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds and was purified by proprietary chromatographic techniques.

Upstream & downstream products

Upstream raw materials

Sodium dithioniteEthanolTriethyl orthoformate5-Amino-1-phenylpyrazoleChlorosulfonic acidEthyl acetateHydrochloric acidSodium hydroxideThionyl chloride4-Nitrobenzenesulfonic acidPhenylhydrazinePetroleum etherPhenylurethaneEthyl cyanoacetate

Additional notes

DefinitionChEBI: A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.